Current status of adjuvant chemotherapy after radical cystectomy for deeply invasive bladder cancer

Urology
D G SkinnerG Lieskovsky

Abstract

Between March, 1976, and December, 1982, 70 of 157 patients (45%) undergoing single-stage radical cystectomy with pelvic lymphadenectomy and urinary diversion with the intent to cure invasive bladder cancer were found to have pathologic Stage P3B, P4 and/or N + disease. Thirty-four of the 70 patients received adjuvant prophylactic chemotherapy after cystectomy and 36 patients were followed expectantly. From 1976 through 1977 adjuvant chemotherapy consisted of cyclophosphamide 1 Gm/M2 each month for six months; from 1978 through June, 1980, adjuvant chemotherapy consisted of cis-platinum 100 mg/M2 each month for four months with the exception of 1 patient treated more aggressively with combination chemotherapy (CISCA). Since July, 1980, a prospective study has been utilized in which patients were randomized into two groups, Group A receiving combination chemotherapy and Group B followed up expectantly; adjuvant chemotherapy appears to result in a slight delay in time to relapse but no influence in overall survival was observed.

References

Jun 15, 1978·The New England Journal of Medicine·S E SalmonT E Moon
Apr 1, 1979·British Journal of Urology·A G TurnerJ S Malpas
Aug 1, 1975·Cancer·S K Carter, T H Wasserman
Jan 1, 1979·Cancer Chemotherapy and Pharmacology·H BushR Barnard
Dec 1, 1978·Cancer·J P DonohueJ M Perez
Nov 21, 1977·JAMA : the Journal of the American Medical Association·J J SternbergD E Johnson
Jan 1, 1978·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·B RichardsP A Smith
Jan 1, 1976·British Journal of Urology·R J CrossR E Williams
Dec 1, 1975·The Journal of Urology·C MerrinG P Murphy
Feb 1, 1974·Annals of Internal Medicine·R H Blum, S K Carter
Feb 1, 1982·British Journal of Urology·R R HallD A Price
Mar 15, 1981·Cancer·R B NataleD W Braun
Jan 1, 1981·Annual Review of Medicine·D G SkinnerJ R Daniels
May 1, 1981·The Journal of Urology·K R KediaL Persky
Nov 1, 1981·The Journal of Urology·A S NarayanaD A Culp
Jan 1, 1982·European Journal of Cancer & Clinical Oncology·J H MulderA T Van Oosterom
Aug 1, 1981·British Journal of Urology·E Garcia-GiraltP Morin
Aug 1, 1981·British Journal of Urology·S D Fosså, T E Gudmundsen

❮ Previous
Next ❯

Citations

Jan 1, 1986·Urological Research·R A Gardiner
Jan 15, 1986·Cancer Genetics and Cytogenetics·A A SandbergF Hecht
Jan 1, 1986·Cancer Genetics and Cytogenetics·A A Sandberg
Nov 1, 1987·Cancer Genetics and Cytogenetics·C FraserD K Kalousek
Oct 1, 1991·Cancer Genetics and Cytogenetics·N Moriyama-GondaT Ishibe
Sep 1, 1992·Clinical Radiology·J E Husband
Jul 23, 2005·Urologia Internationalis·Giacomo NovaraWalter Artibani
Oct 18, 2007·Urologia Internationalis·Ubirajara FerreiraMarjo Deninson Cardenuto Perez
Jan 1, 2008·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Makarand V Khochikar
Apr 9, 2005·Surgical Oncology Clinics of North America·Federico A Corica, Thomas E Keane
May 31, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·N IsmailiH Errihani
May 17, 2003·Der Urologe. Ausg. A·M-O GrimmW A Schulz
Jan 1, 1987·Scandinavian Journal of Urology and Nephrology·S D FossåP Ogreid
May 1, 1993·The Journal of Urology·J B Thrasher, E D Crawford
Feb 1, 1994·Critical Reviews in Oncology/hematology·G J BoslH I Scher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.